Is your metabolism determined by (cell) fate?

Pediatric Research

Volumn 61, Issue 6, 2007, Pages 636-639

  Feldman, Brian J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; GLUCOCORTICOID; MYOSTATIN;

ADIPOCYTE; ADIPOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CHILD; CUSHING SYNDROME; GENE CONTROL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MESENCHYME; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CHILD; CUSHING SYNDROME; FATS; GLUCOCORTICOIDS; HUMANS; METABOLIC DISEASES; MICE;

EID: 34249105475     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/pdr.0b013e31805d854e     Document Type: Review

References (20)

1. Townsend HB, Saag KG 2004 Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks. Clin Exp Rheumatol 22:S77-S82
2. Adcock IM 2003 Glucocorticoids: new mechanisms and future agents. Curr Allergy Asthma Rep 3:249-257
3. Almawi WY, Hess DA, Rieder MJ 1998 Multiplicity of glucocorticoid action in inhibiting allograft rejection. Cell Transplant 7:511-523
4. Bolt RJ, van Weissenbrunch M, Lafeber H, Delemarre-van de Wall H 2001 Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 32:76-91
5. Warrell RP, de The H, Wang Z-Y, Degos L 1993 Acute Promyelocytic Leukemia. N Engl J Med 329:177-189
6. Ross RA, Hein AM, Braca JA 3rd, Spengler BA, Biedler JL, Scammell JG 2002 Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells. Oncol Res 13:87-94
7. Schacke H, Docke WD, Asadullah K 2002 Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43
8. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602
9. Seckl JR, Morton NM, Chapman KE, Walker BR 2004 Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue. Recent Prog Horm Res 59:359-393
10. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
11. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A Transgenic Model of Visceral Obesity and the Metabolic Syndrome. Science 294:2166-2170
12. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR 2001 Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300
13. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938
14. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ 2004 Metabolic syndrome without obesity: Hepatic overexpression of 11{beta}-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 101:7088-7093
15. Crossno JT, Majka SM, Grazia T, Gill RG, Klemm DJ 2006 Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 116:3220-3228
16. Pinney DF, Emerson CPJr. 1989 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect 80:221-227
17. Rogers JJ, Young HE, Adkison LR, Lucas PA, Black ACJr 1995 Differentiation factors induce expression of muscle, fat, cartilage, and bone in a clone of mouse pluripotent mesenchymal stem cells. Am Surg 61:231-236.
18. MacDougald OA, Mandrup S 2002 Adipogenesis: forces that tip the scales. Trends Endocrinol Metab 13:5-11
19. Feldman BJ, Streeper RS, Farese RV Jr, Yamamoto KR 2006 Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA 103:15675-15680
20. McPherron AC, Lee SJ 2002 Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109:595-601